Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

There was also a clear correlation between fluoride activity and PTH, but not between fluoride activity and tALP, Table S1.Characteristics of the study groupNo. of patients26Female sex (%)13 (50)Age, year (median, range)66 (37 to 83)BMI (mean, SD)23.9 ± 3.5Smoker (%)6 (23)History of diabetes (%)9 (35)Dialysis vintage, month (median, range)10 (6 to 37)Laboratory parameters fS-calcium-ion 1.16 to 1.13 mmol/l (median, IQR)1.17 (1.11 to 1.23) fP-phosphorus 0.71 to 1.23 mmol/l (median, IQR)1.61 (1.41 to 1.99) fP-PTH 15 to 65 ng/l (median, IQR)285 (178 to 537) P-D-25 > 50 nmol/l (median, IQR)70 (40 to 94) S-D-125 37 to 216 pmol/l (median, IQR)30 (24 to 58) P-tALP 35 to 105 U/l (median, IQR)88 (67 to 132) P-Alb 36 to 45 g/l (median, IQR)31.9 (27.8 to 33.6)Medication Calcimimetic (%)4 (15) Alfacalcidol, Paricalcitol (%)14 (58) Calcium carbonate (%)22 (85) Cholecalciferol (%)23 (88) Sevelamer/lantane carbonate (%)16 (62) Corticosteroid (%)2 (8)

Source: General. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

In this cross-sectional study, 26 patients on dialysis underwent a 18F-NaF PET and a bone biopsy.

Source: Abstract.

The range for normal turnover in men was: BFR/BS 3.6 to 18.8 µm/year and Ac.f 0.12 to 0.6, in postmenopausal women: BFR/BS 6 to 22 µm/year and Ac.f 0.11 to 0.49/year and in premenopausal women: BFR/BS 3 to 13 µm/year and Ac.f 0.04 to 0.26/year.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Bone Histomorphometry and 18F-Sodium Fluoride Positron Emission Tomography Imaging: Comparison Between only Bone Turnover-based and Unified TMV-based Classification of Renal Osteodystrophy

Cross-sectional study · Calcified Tissue International · 2021

Original publication title

Bone Histomorphometry and 18F-Sodium Fluoride Positron Emission Tomography Imaging: Comparison Between only Bone Turnover-based and Unified TMV-based Classification of Renal Osteodystrophy

Louise Aaltonen; Niina Koivuviita; Marko Seppänen; Inari S. Burton; Heikki Kröger; Eliisa Löyttyniemi; Kaj Metsärinne

© The Author(s) 2021

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Bone biopsy is the gold standard for characterization of renal osteodystrophy (ROD). However, the classification of the subtypes of ROD based on histomorphometric parameters is not unambiguous and the range of normal values for turnover differ in different publications. 18F-Sodium Fluoride positron emission tomography (18F-NaF PET) is a dynamic imaging technique that measures turnover. 18F-NaF PET has previously been shown to correlate with histomorphometric parameters. In this cross-sectional study, 26 patients on dialysis underwent a 18F-NaF PET and a bone biopsy.

Bone turnover-based classification was assessed using Malluche’s historical reference values for normal bone turnover. In unified turnover-mineralization-volume (TMV)-based classification, the whole histopathological picture was evaluated and the range for normal turnover was set accordingly. Fluoride activity was measured in the lumbar spine (L1: L4) and at the anterior iliac crest. On the basis of turnover-based classification of ROD, 12% had high turnover and 61% had low turnover bone disease. On the basis of unified TMV-based classification of ROD, 42% had high turnover/hyperparathyroid bone disease and 23% had low turnover/adynamic bone disease.

When using unified TMV-based classification of ROD, 18F-NaF PET had an AUC of 0.86 to discriminate hyperparathyroid bone disease from other types of ROD and an AUC of 0.87, for discriminating adynamic bone disease. There was a disproportion between turnover-based classification and unified TMV-based classification. More research is needed to establish normal range of bone turnover in patients with CKD and to establish the role of PET imaging in ROD.

Supplementary Information

The online version contains supplementary material available at 10.1007/s00223-021-00874-9.

Authors’ abstract

Bone biopsy is the gold standard for characterization of renal osteodystrophy (ROD). However, the classification of the subtypes of ROD based on histomorphometric parameters is not unambiguous and the range of normal values for turnover differ in different publications. 18F-Sodium Fluoride positron emission tomography (18F-NaF PET) is a dynamic imaging technique that measures turnover. 18F-NaF PET has previously been shown to correlate with histomorphometric parameters. In this cross-sectional study, 26 patients on dialysis underwent a 18F-NaF PET and a bone biopsy.

Bone turnover-based classification was assessed using Malluche’s historical reference values for normal bone turnover. In unified turnover-mineralization-volume (TMV)-based classification, the whole histopathological picture was evaluated and the range for normal turnover was set accordingly. Fluoride activity was measured in the lumbar spine (L1: L4) and at the anterior iliac crest. On the basis of turnover-based classification of ROD, 12% had high turnover and 61% had low turnover bone disease. On the basis of unified TMV-based classification of ROD, 42% had high turnover/hyperparathyroid bone disease and 23% had low turnover/adynamic bone disease.

When using unified TMV-based classification of ROD, 18F-NaF PET had an AUC of 0.86 to discriminate hyperparathyroid bone disease from other types of ROD and an AUC of 0.87, for discriminating adynamic bone disease. There was a disproportion between turnover-based classification and unified TMV-based classification. More research is needed to establish normal range of bone turnover in patients with CKD and to establish the role of PET imaging in ROD.

Supplementary Information

The online version contains supplementary material available at 10.1007/s00223-021-00874-9.

Publication and source details

Original title: Bone Histomorphometry and 18F-Sodium Fluoride Positron Emission Tomography Imaging: Comparison Between only Bone Turnover-based and Unified TMV-based Classification of Renal Osteodystrophy

Louise Aaltonen; Niina Koivuviita; Marko Seppänen; Inari S. Burton; Heikki Kröger; Eliisa Löyttyniemi; Kaj Metsärinne

Calcified Tissue International · 2021

© The Author(s) 2021https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.http://dx.doi.org/10.13039/100010119Stiftelsen Dorothea Olivia, Karl Walter och Jarl Walter Perkléns Minnehttp://dx.doi.org/10.13039/100010135Finska LäkaresällskapetMunuaissäätiöUniversity of Turku (UTU) including Turku University Central Hospital

Open access funding provided by University of Turku (UTU) including Turku University Central Hospital.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T12:24:04.927849+00:00

DOI: 10.1007/s00223-021-00874-9 · PMC8531121